EXE — Extendicare Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapSuper Stock

Annual income statement for Extendicare, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	R2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,104	1,167	1,222	1,305	1,466
Cost of Revenue
Gross Profit	181	133	109	151	201
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	1,015	1,132	1,210	1,245	1,351
Operating Profit	88.7	34.7	11.9	60.3	115
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	58.7	14	-4.5	44.8	99.9
Provision for Income Taxes
Net Income After Taxes	42.5	7.5	-4.51	34	75.2
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	54.2	11.5	69.6	34	75.2
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	54.2	17.7	75.8	34	81.9
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.149	0.123	0.122	0.424	0.846
Dividends per Share